Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Should hydroxychloroquine be stopped prior to standard or hypofractionated breast treatment?
Answer from: Radiation Oncologist at Community Practice
We don’t stop hydroxychloroquine for RT.
Sign In
or
Register
to read more
9397
Related Questions
For a patient who previously underwent PBI and then developed a second ipsilateral primary, would you offer repeat PBI?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
How do you manage a symptomatic primary breast tumor in a patient with metastatic disease?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
How would you approach reirradiation in a patient with a history of whole-breast RT many years ago, now with a small intermediate-grade DCIS s/p lumpectomy with an elevated DCISionRT?
Does pre-chemotherapy extent of nodal involvement impact your decision to offer adjuvant radiation in cN1, ypN0 triple-negative breast cancer?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?
What are your top takeaways in Breast Cancer from ESMO 2025?
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?